chromomycin-a3 and Fibrosarcoma

chromomycin-a3 has been researched along with Fibrosarcoma* in 2 studies

Other Studies

2 other study(ies) available for chromomycin-a3 and Fibrosarcoma

ArticleYear
Flow analysis and sorting of microchromosomes (<3 Mb).
    Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2007, Volume: 71, Issue:6

    The analysis and isolation of high numbers of chromosomes smaller than 3 Mb in size (microchromosomes) with good purity is dependent primarily on the detection sensitivity of the flow cytometer and the precision of the sort unit. The aim of this study was to investigate the capability of using a conventional flow cytometer for the detection and sorting at high purity microchromosomes with an estimated size of 2.7 Mb.. Chromosomes were isolated from a human cell line containing a pair of X-derived microchromosomes, using a modified polyamine isolation buffer. The chromosome preparation was labeled with Hoechst and Chromomycin and analyzed and purified using a MoFlo sorter (DAKO) configured for high-speed sorting. The purity of the flow-sorted microchromosomes was assessed by reverse chromosome painting.. Improved resolution of the peak of microchromosomes in a bivariate plot of Hoechst versus Chromomycin fluorescence was obtainable after discriminating clumps and debris based on gating data within a FSC versus pulse width plot.. Chromosomes of smaller size, less than 3 Mb, can be detected with high resolution and flow-sorted with high purity using a conventional flow sorter.

    Topics: Benzimidazoles; Buffers; Cell Line, Tumor; Chromomycin A3; Chromosome Painting; Chromosomes, Human, X; DNA; Fibrosarcoma; Flow Cytometry; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Humans; Karyotyping; Polyamines; Reproducibility of Results

2007
Induction of natural killer (NK) activity in mice by injection of chromomycin A3.
    The Tohoku journal of experimental medicine, 1991, Volume: 163, Issue:4

    Intravenously or intraperitoneally administered Chromomycin A3 (CHRM), an anticancer drug, augmented natural killer (NK) activity of both spleen cells and peritoneal exudate cells in BALB/c mice. When CHRM was administered intravenously, NK activity increased to about five fold that in nontreated mice on the 3rd to the 5th day, then rapidly decreased by the 7th day. On the other hand, when CHRM was administered by the intraperitoneal route, a peak of increased NK activity was observed on 5th to 7th day followed by a more gentle decrease. Augmentation of NK activity by CHRM was enhanced by additional administration of Interferon- gamma (IFN-gamma). Experimental evidence that NK activity could be augmented by CHRM in various strains of mice, independent of H-2 haplotype, suggested that involvement of genetic control within class I region of major histocompatibility complex could be excluded. When BALB/c mice inoculated subcutaneously with Meth A cells were treated with i.p. injection of CHRM, or CHRM in combination with IFN-gamma, the growth of the tumor cells was inhibited, indicating in vivo significance for the increased NK activity. Since this inhibitory effect was decreased by the injection of anti Asialo GM1 antibody (alpha-ASGM1), the effector cells presumably exerting killing activity against Meth A cells were concluded to be Asialo GM1 antigen positive.

    Topics: Animals; Ascitic Fluid; Autoradiography; Cells, Cultured; Chromomycin A3; Fibrosarcoma; G(M1) Ganglioside; Genes, MHC Class I; Glycosphingolipids; Interferon-gamma; Killer Cells, Natural; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Spleen

1991